OverviewSuggest Edit

Based on advances in chemical biology and network science, network pharmacology is a distinctive new approach to drug discovery. It involves application of network analysis to determine the set of proteins most critical in any disease, and then chemical biology to identify molecules capable of targeting that set of proteins. By addressing the true complexity of disease and by seeking to harness the ability of drugs to influence many different proteins, network pharmacology differs from conventional drug discovery approaches, which have generally been based on highly specific targeting of a single protein. Network pharmacology has the potential to provide new treatments for complex diseases where conventional approaches have failed to deliver satisfactory therapies.

TypePublic
Founded2003
HQLong Hanborough, GB
Websiteetherapeutics.co.uk

Locations

E-Therapeutics is headquartered in
Long Hanborough, United Kingdom

Location Map

Latest Updates

Employees (est.) (Jan 2018)20(-16%)
Revenue (FY, 2019)£44 K
Share Price (Oct 2017)£0.1 (+3%)

E-Therapeutics Office Locations

E-Therapeutics has offices in Long Hanborough and Newcastle upon Tyne
Long Hanborough, GB (HQ)
Blenheim Office Park, 17 Fenlock Rd
Newcastle upon Tyne, GB
11 Waterloo St
Show all (2)

E-Therapeutics Financials and Metrics

E-Therapeutics Revenue

E-Therapeutics's revenue was reported to be £44 k in FY, 2019
GBP

Revenue (FY, 2019)

44.0k

Net income (FY, 2019)

(4.0m)

EBITDA (FY, 2019)

(5.1m)

EBIT (FY, 2019)

(5.1m)

Market capitalization (31-Oct-2017)

27.2m

Closing stock price (31-Oct-2017)

0.1

Cash (31-Jan-2019)

5.9m
E-Therapeutics's current market capitalization is £27.2 m.
GBPFY, 2017FY, 2018FY, 2019

Revenue

44.0k

Operating expense total

5.2m

EBITDA

(16.3m)(6.7m)(5.1m)

EBITDA margin, %

(11500%)
GBPFY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.0100.0100.02.0m409.0k2.9m927.0k6.2m9.8m43.1m33.8m24.8m14.0m7.1m5.9m

Accounts Receivable

1.4m

Current Assets

1.01.0100.0100.0872.2k2.0m2.6m1.0m3.4m1.4m14.8m10.9m45.0m37.4m28.8m17.7m11.6m7.3m

PP&E

64.8k27.4k56.0k42.0k30.0k16.0k137.0k150.0k121.0k96.0k64.0k51.0k71.0k42.0k
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(2.0m)(1.5m)(1.8m)(2.3m)(3.2m)(4.2m)(5.0m)(7.8m)(8.8m)(13.1m)(5.4m)(4.0m)

Cash From Operating Activities

(2.2m)(1.5m)(1.7m)(1.9m)(3.2m)(4.2m)(5.7m)(9.9m)(9.2m)(9.4m)(4.4m)(3.7m)

Cash From Financing Activities

4.1m4.4m82.0k16.4m15.0k39.0m77.0k12.0k13.0k12.0k11.0k

Net Change in Cash

1.8m(1.6m)2.5m(2.0m)5.2m(1.9m)2.7m(5.1m)4.5m(1.9m)2.6m(1.2m)
GBPY, 2019

Financial Leverage

1.1 x
Show all financial metrics

E-Therapeutics Operating Metrics

E-Therapeutics's Projects Launched was reported to be 12 in FY, 2016.
FY, 2015FY, 2016

Projects Launched

6 12
Show all operating metrics

E-Therapeutics Online and Social Media Presence

Embed Graph

E-Therapeutics Frequently Asked Questions

  • When was E-Therapeutics founded?

    E-Therapeutics was founded in 2003.

  • How many employees does E-Therapeutics have?

    E-Therapeutics has 20 employees.

  • What is E-Therapeutics revenue?

    Latest E-Therapeutics annual revenue is £44 k.

  • What is E-Therapeutics revenue per employee?

    Latest E-Therapeutics revenue per employee is £2.2 k.

  • Who are E-Therapeutics competitors?

    Competitors of E-Therapeutics include Opiant Pharmaceuticals, Vitality Biopharma and IntelGenx.

  • Where is E-Therapeutics headquarters?

    E-Therapeutics headquarters is located at Blenheim Office Park, 17 Fenlock Rd, Long Hanborough.

  • Where are E-Therapeutics offices?

    E-Therapeutics has offices in Long Hanborough and Newcastle upon Tyne.

  • How many offices does E-Therapeutics have?

    E-Therapeutics has 2 offices.